{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:58:41Z","timestamp":1758052721416,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.clinbiochem.2011.04.022","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T15:25:14Z","timestamp":1304781914000},"page":"809-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two novel alpha-galactosidase A mutations causing Fabry disease: A missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man"],"prefix":"10.1016","volume":"44","author":[{"given":"Basak","family":"Celtikci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Top\u00e7u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Asuman","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0005","series-title":"The metabolic and molecular basis of inherited disease","first-page":"3733","article-title":"alpha-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clinbiochem.2011.04.022_bb0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.braindev.2003.09.006","article-title":"Sphingolipidoses in Turkey","volume":"26","author":"Ozkara","year":"2004","journal-title":"Brain Dev"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","article-title":"Fabry disease: 45 novel mutations in the \u03b1-galactosidase A gene causing the classical phenotype","volume":"76","author":"Shabbeer","year":"2002","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.clinbiochem.2011.04.022_bb0025","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/nar\/17.8.3301","article-title":"Nucleotide sequence of human alpha-galactosidase A gene","volume":"17","author":"Kornreich","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0035","first-page":"319","article-title":"The molecular defects leading to Fabry disease: structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out method for extracting DNA from nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0076-6879(87)38063-2","article-title":"Enzymatic diagnosis of sphingolipidoses","volume":"138","author":"Suzuki","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1399-0004.2003.00050.x","article-title":"Two novel mutations in the a-galactosidase A gene in Chinese patients with Fabry disease","volume":"63","author":"Yang","year":"2003","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.clinbiochem.2011.04.022_bb0060","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI118981","volume":"98","author":"Miyamura","year":"1996","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.04.022_bb0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/mgme.1998.2742","article-title":"At least six different mutations in HEXA gene cause Tay\u2013Sachs disease among the Turkish population","volume":"65","author":"Ozkara","year":"1998","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1016\/j.clinbiochem.2011.04.022_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/GIM.0b013e3181f6e676","article-title":"Therapeutic goals in the treatment of Fabry disease","volume":"12","author":"Mehta","year":"2010","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.clinbiochem.2011.04.022_bb0075","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/GIM.0b013e3181f13b75","article-title":"Effects of enzyme replacement therapy in Fabry disease-a comprehensive review of the medical literature","volume":"12","author":"Lidove","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the a-galactosidase a gene in patients with classic and variant phenotypes","volume":"3","author":"Eng","year":"1997","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.04.022_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.1380050316","article-title":"Two novel mutations (L32P) and (G85N) among five different missense mutations in six Danish families with Fabry's disease","volume":"5","author":"Madsen","year":"1995","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/humu.9327","article-title":"Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease","volume":"25","author":"Schafer","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1651-2227.2005.tb02119.x","article-title":"Gal A: genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey","volume":"94","author":"Schaefer","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0105","series-title":"JIMD Online Report #003","article-title":"Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease","author":"Kobayashi","year":"2008"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/bj3320789","article-title":"Human a-galactosidase A: glycosylation site 3 is essential for enzyme solubility","volume":"332","author":"Ioannou","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1096-7192(02)00151-8","article-title":"Structural basis of Fabry disease","volume":"77","author":"Garman","year":"2002","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.clinbiochem.2011.04.022_bb0135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF03402156","article-title":"Fabry disease: twenty novel alpha-galactosidase A mutations and genotype\u2013phenotype correlations in classical and variant phenotypes","volume":"8","author":"Germain","year":"2002","journal-title":"Mol Med"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1034\/j.1399-0004.2001.600107.x","article-title":"Identification of fifteen novel mutations and genotype\u2013phenotype relationship in Fabry disease","volume":"60","author":"Altarescu","year":"2001","journal-title":"Clin Genet"},{"key":"10.1016\/j.clinbiochem.2011.04.022_bb0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pcad.2009.11.002","article-title":"Anderson\u2013Fabry disease and the heart","volume":"52","author":"O'Mahony","year":"2010","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011003274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011003274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:35:15Z","timestamp":1757864115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912011003274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0009912011003274"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.04.022","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two novel alpha-galactosidase A mutations causing Fabry disease: A missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}